MIM
OFIX icon

Macroview Investment Management’s Orthofix Medical OFIX Stock Holding History

Macroview Investment Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-56
Closed -$3K – 346
2018
Q2 		$3K Buy
+56
New +$3.19K 0.01% 205

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Macroview Investment Management's OFIX Position: Q3 2018 in Review

Macroview Investment Management sold out of Orthofix Medical (OFIX) in Q3 2018, closing a stake of 56 shares — an estimated $3K sold.

Macroview Investment Management first reported a position in OFIX in Q2 2018 and held it in 1 quarter. The position peaked at $3K in Q2 2018. 162 funds tracked by Wall St. Rank hold OFIX as of Q3 2018.

  • Macroview Investment Management reported no remaining Orthofix Medical position as of Q3 2018 after selling out during the quarter.
  • Macroview Investment Management sold 56 Orthofix Medical shares in Q3 2018, an estimated $3K.
  • Macroview Investment Management first reported a position in Orthofix Medical in Q2 2018 and held it in 1 quarter.
  • Macroview Investment Management's Orthofix Medical position peaked at $3K in Q2 2018.
  • 162 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2018.

Based on Macroview Investment Management's 13F filing for Q3 2018, filed 2 Nov 2018.